From: Role of fibroblast growth factors in bone regeneration
Growth factor | Dose | In vivo model | Carrier | Investigations | Effect | References |
---|---|---|---|---|---|---|
FGF2 | 200 μg | Monkey ulna fracture | Injectable gelatin hydrogel | Bone mineral content and mechanical properties | Accelerates fracture healing and prevents nonunion | [67] |
FGF2 | 2.5 μg | Rat periodontal defect (2 × 2 × 1.7 mm) | Injectable calcium phosphate cement | Histology and histomorphometry of bone | Increased periodontal regeneration | [68] |
FGF2 | 50 μg | Rat calvarial defect (4-mm diameter) | PLGA/β-TCP | Histomorphometry of bone | Enhanced bone regeneration | [69] |
FGF2 | 50 μg/ml | Rat calvarial defect (5-mm diameter) | Collagen and nano-bioactive glass hybrid membrane | Histomorphometry of bone | Accelerated bone regeneration | [70] |
FGF2 | 45 μg | Rabbit femoral condyle (4-mm diameter and 6 mm long) | Hydrogel polymer | Bone mass and microarchitecture | Enhanced bone regeneration | [32] |
FGF2 | 10 μg | Rat tibia (2-mm diameter, 4 mm long) | Titanium implant | Bone histomorphometry | Synergistically enhanced new bone formation | [71] |
Melatonin | 100Â mg/kg i.p. | |||||
FGF2 | 200, 400, or 800 μg | Human tibia (high tibial osteotomy) | Gelatin hydrogel | Radiographic assessment of bone | Dose dependently accelerated bone union | [72] |
FGF2 | 100 μg | Rabbit femoral condyle (10 mm2 × 5 mm depth) | Interconnected porous calcium hydroxyapatite ceramic | Bone histomorphometry | Decreases lamellar bone formation, increases vascularization and osseointegration | [73] |
FGF2 | 0, 25, or 250Â ng | Rat calvarial defect (3.5-mm diameter) | PLGA/gelatin | Radiological, histological, and biochemical examination | Low-dose administration enhanced the degree of calcification and ALP activity | [74] |
BMP2 | 0.1Â mg/ml | |||||
FGF9 | 2 μg | Mouse tibia (1-mm defect) | Collagen sponge | Bone histomorphometry | Enhances angiogenesis and bone regeneration | [19] |